Emily Charlotte Stanyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emily Charlotte Stanyer has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Jan Hoffmann
King's College London
4 shared publications - Philip Robert Holland
Headache Group, Wolfson Sensory Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
4 shared publications - Shaun Davidson
University of Oxford
2 shared publications - Simon David Kyle
John Radcliffe Hospital, NIHR Oxford Biomedical Research Centre, Oxford, UK
2 shared publications A.D. Nesbitt
Department of Neurology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
1 shared publicationAlexander David Nesbitt
From the Wolfson Centre for Age-Related Diseases (E.C.S., H.C., P.R.H., J.H.), Institute of Psychiatry, Psychology & Neuroscience, King's College London; Department of Neurology (A.D.N.), Guy's and St Thomas NHS Foundation Trust; and NIHR-Wellcome Trust King's Clinical Research Facility/SLaM Biomedical Research Centre (J.H.), King's College Hospital, London, UK
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by Springer Nature
Understanding brain networks in people with insomnia and low mood following behavioural sleep treatment
- 17 September 2026
- Published by Springer Nature
Open AccessUnderstanding brain networks in people with insomnia and low mood following behavioural sleep treatment
- Open Access
Insights from nine nights of self-applied, low-density sleep EEG during sleep restriction therapy: a proof-of-concept evaluation
Objectives: Self-applied, low-density EEG offers opportunities to examine sleep in the home environment, yet its feasibility during behavioural sleep interventions remains unexplored. This pilot study aimed to evaluate the feasibility and acceptability of a self-applied, low-density EEG device during sleep restriction therapy (SRT) and explore effects on sleep and affect. Methods: Seventeen adults with insomnia and depressive symptoms completed a 2-week baseline and 4 weeks of SRT. The primary outcome was the proportion of expected EEG recordings completed and scoreable. Secondary outcomes included clinical measures, sleep continuity (sleep diary, actigraphy), sleep architecture (low-density EEG for 9 nights), power spectral density, and affect. Data were analysed with linear mixed models. Cohen's d and 95% confidence intervals were reported. Results: Feasibility was demonstrated (92% of expected EEG nights completed). SRT was associated with reductions in insomnia severity, depressive symptoms, negative affect, and increases in positive affect. Robust improvements were observed across treatment in sleep continuity (SOL, WASO, SE) from diary, which were paralleled by actigraphy. EEG revealed reduced TIB, TST, N1, N2, REM sleep, and REM latency during week one. Reductions in EEG-derived TIB and N1 sleep were maintained at night 28. There were no reliable differences for spectral or spindle measures. Conclusions: These findings suggest that self-applied, low-density EEG during SRT is feasible, acceptable, and may capture sleep changes during treatment. They highlight the potential for multi-night monitoring of sleep interventions at home and elucidating mechanisms underlying therapeutic change.
Open AccessInsights from nine nights of self-applied, low-density sleep EEG during sleep restriction therapy: a proof-of-concept evaluation
Objectives: Self-applied, low-density EEG offers opportunities to examine sleep in the home environment, yet its feasibility during behavioural sleep interventions remains unexplored. This pilot study aimed to evaluate the feasibility and acceptability of a self-applied, low-density EEG device during sleep restriction therapy (SRT) and explore effects on sleep and affect. Methods: Seventeen adults with insomnia and depressive symptoms completed a 2-week baseline and 4 weeks of SRT. The primary outcome was the proportion of expected EEG recordings completed and scoreable. Secondary outcomes included clinical measures, sleep continuity (sleep diary, actigraphy), sleep architecture (low-density EEG for 9 nights), power spectral density, and affect. Data were analysed with linear mixed models. Cohen's d and 95% confidence intervals were reported. Results: Feasibility was demonstrated (92% of expected EEG nights completed). SRT was associated with reductions in insomnia severity, depressive symptoms, negative affect, and increases in positive affect. Robust improvements were observed across treatment in sleep continuity (SOL, WASO, SE) from diary, which were paralleled by actigraphy. EEG revealed reduced TIB, TST, N1, N2, REM sleep, and REM latency during week one. Reductions in EEG-derived TIB and N1 sleep were maintained at night 28. There were no reliable differences for spectral or spindle measures. Conclusions: These findings suggest that self-applied, low-density EEG during SRT is feasible, acceptable, and may capture sleep changes during treatment. They highlight the potential for multi-night monitoring of sleep interventions at home and elucidating mechanisms underlying therapeutic change.
- Open Access
Longitudinal Cardiorespiratory Wearable Sleep Staging in the Home
There is a growing interest in performing automated, longitudinal tracking of sleep in the home environment using wearables and machine learning. Wearables such as smart watches or chest patches can be comfortably worn for long periods of time, and cardiorespiratory waveforms measured by these wearables combined with machine learning models to estimate sleep state. However, these machine learning models are typically trained and tested on retrospective data from sleep labs, where cardiorespiratory waveforms are monitored using bulky, specialised equipment rather than wearables. As such, these models have yet to be validated in their intended scenario of use: longitudinal, wearable sleep monitoring in the home. This paper establishes and validates a pipeline for longitudinal cardiorespiratory sleep monitoring in the home using data from the RESTORE study. In RESTORE, 17 participants with a sleep-related condition (insomnia and depressive symptoms) underwent a sleep-related clinical intervention (sleep restriction therapy). Participants simultaneously wore a low-density home electroencephalogram device, allowing for expert, manual sleep staging using brain activity, as well as a wearable chest patch, allowing for wearable monitoring of cardiorespiratory waveforms. Both devices were worn by participants for 10 nights while undergoing treatment at home. A state-of-the-art cardiorespiratory sleep staging model, combining transformer and convolutional neural networks, was then tuned and tested on the wearable data using leave-one-subject-out-cross-validation. After transfer learning, the cardiorespiratory sleep staging model had an accuracy of 77.1% and Cohen’s Kappa of 0.679 for four-class sleep staging using the wearable data from the RESTORE study. Further, the model was able to accurately track sleep and sleep-derived metrics longitudinally while participants underwent sleep restriction therapy. These results represent one of the first direct demonstrations of the potential for wearable, cardiorespiratory sleep staging to track longitudinal, clinically relevant changes in sleep in individuals undergoing a sleep-related intervention in the home.
Open AccessLongitudinal Cardiorespiratory Wearable Sleep Staging in the Home
There is a growing interest in performing automated, longitudinal tracking of sleep in the home environment using wearables and machine learning. Wearables such as smart watches or chest patches can be comfortably worn for long periods of time, and cardiorespiratory waveforms measured by these wearables combined with machine learning models to estimate sleep state. However, these machine learning models are typically trained and tested on retrospective data from sleep labs, where cardiorespiratory waveforms are monitored using bulky, specialised equipment rather than wearables. As such, these models have yet to be validated in their intended scenario of use: longitudinal, wearable sleep monitoring in the home. This paper establishes and validates a pipeline for longitudinal cardiorespiratory sleep monitoring in the home using data from the RESTORE study. In RESTORE, 17 participants with a sleep-related condition (insomnia and depressive symptoms) underwent a sleep-related clinical intervention (sleep restriction therapy). Participants simultaneously wore a low-density home electroencephalogram device, allowing for expert, manual sleep staging using brain activity, as well as a wearable chest patch, allowing for wearable monitoring of cardiorespiratory waveforms. Both devices were worn by participants for 10 nights while undergoing treatment at home. A state-of-the-art cardiorespiratory sleep staging model, combining transformer and convolutional neural networks, was then tuned and tested on the wearable data using leave-one-subject-out-cross-validation. After transfer learning, the cardiorespiratory sleep staging model had an accuracy of 77.1% and Cohen’s Kappa of 0.679 for four-class sleep staging using the wearable data from the RESTORE study. Further, the model was able to accurately track sleep and sleep-derived metrics longitudinally while participants underwent sleep restriction therapy. These results represent one of the first direct demonstrations of the potential for wearable, cardiorespiratory sleep staging to track longitudinal, clinically relevant changes in sleep in individuals undergoing a sleep-related intervention in the home.
- Open Access
- 22 March 2024
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 24 (5) , 487-496
Orexins and primary headaches: an overview of the neurobiology and clinical impact
1. Primary headache disorders are highly prevalent [1,2] and disabling conditions [3] which significantly impact quality of life [4]. These include migraine, tension-type headache, and several trig...
- 22 March 2024
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 24 (5) , 487-496
Open AccessOrexins and primary headaches: an overview of the neurobiology and clinical impact
1. Primary headache disorders are highly prevalent [1,2] and disabling conditions [3] which significantly impact quality of life [4]. These include migraine, tension-type headache, and several trig...
- Open Access
Establishing Causality in the Relationship between Sleep and Migraine in a Global Sample: A Bayesian Approach
Background: There is a bidirectional link between sleep and migraine, however causality is difficult to determine. Previous studies rely on retrospective questionnaires, and small samples to support their findings. This study aimed to overcome this by teasing apart this relationship using sleep assessment and concomitant migraine data collected from a smartphone application using Bayesian modelling. Methods: Anonymized self-reported data on sleep and migraine from 11,166 global users (aged 18-81 years, mean: 41.21, standard deviation: 11.49) were collected from the Migraine Buddy application (Healint Pte. Ltd.) between 30 th June and 31 st December 2021. Measures included: demographics, start and end times of each sleep episode and migraine attack, and the pain intensity for each migraine attack (visual analogue scale 0-10). Bayesian regression models were used to predict occurrence of a migraine attack the next day based on users’ deviations from mean monthly sleep, number of sleep interruptions, and hours slept the night before in those reporting ≥ 4 and SD = 11.63), with a mean monthly number of attacks of 9.94. A greater number of sleep interruptions (95% Highest Density Interval (95% HDI [0.112 – 0.205]) and deviation from a user’s mean sleep the night before (95% HDI [0.040 – 0.080]) were significant predictors of a next day migraine attack. Total hours slept was not a significant predictor (95% HDI [-0.04 – 0.04]). Pain intensity, but not attack occurrence was a positive predictor of hours slept. Discussion: Sleep fragmentation and deviation from typical sleep are the main drivers of the relationship between sleep and migraine, whereas overall sleep duration is not. Conversely, simply having a migraine attack does not predict sleep duration, it is the pain associated with an attack which alters sleep. This study has shed light on the causal mechanisms of sleep and migraine and highlights sleep hygiene as crucial in migraine management.
Open AccessEstablishing Causality in the Relationship between Sleep and Migraine in a Global Sample: A Bayesian Approach
Background: There is a bidirectional link between sleep and migraine, however causality is difficult to determine. Previous studies rely on retrospective questionnaires, and small samples to support their findings. This study aimed to overcome this by teasing apart this relationship using sleep assessment and concomitant migraine data collected from a smartphone application using Bayesian modelling. Methods: Anonymized self-reported data on sleep and migraine from 11,166 global users (aged 18-81 years, mean: 41.21, standard deviation: 11.49) were collected from the Migraine Buddy application (Healint Pte. Ltd.) between 30 th June and 31 st December 2021. Measures included: demographics, start and end times of each sleep episode and migraine attack, and the pain intensity for each migraine attack (visual analogue scale 0-10). Bayesian regression models were used to predict occurrence of a migraine attack the next day based on users’ deviations from mean monthly sleep, number of sleep interruptions, and hours slept the night before in those reporting ≥ 4 and SD = 11.63), with a mean monthly number of attacks of 9.94. A greater number of sleep interruptions (95% Highest Density Interval (95% HDI [0.112 – 0.205]) and deviation from a user’s mean sleep the night before (95% HDI [0.040 – 0.080]) were significant predictors of a next day migraine attack. Total hours slept was not a significant predictor (95% HDI [-0.04 – 0.04]). Pain intensity, but not attack occurrence was a positive predictor of hours slept. Discussion: Sleep fragmentation and deviation from typical sleep are the main drivers of the relationship between sleep and migraine, whereas overall sleep duration is not. Conversely, simply having a migraine attack does not predict sleep duration, it is the pain associated with an attack which alters sleep. This study has shed light on the causal mechanisms of sleep and migraine and highlights sleep hygiene as crucial in migraine management.
- Retracted
- 30 November 2021
- Published by Wiley in Journal of Sleep Research
- Vol. 31 (3) , e13385
RETRACTED: The impact of acoustic stimulation during sleep on memory and sleep architecture: A meta‐analysis
Summary: The relationship between sleep and cognition has long been recognized, with slow‐wave sleep thought to play a critical role in long‐term memory consolidation. Recent research has presented the possibility that non‐invasive acoustic stimulation during sleep could enhance memory consolidation. Herein, we report a random‐effects model meta‐analysis examining the impact of this intervention on memory and sleep architecture in healthy adults. Sixteen studies were identified through a systematic search. We found a medium significant effect of acoustic stimulation on memory task performance (g = 0.68, p = .031) in young adults 35 years of age (g = −0.83, p = .223). In young adults, there was a large statistically significant effect for declarative memory tasks (g = 0.87, p = .014) but no effect for non‐declarative tasks (g = −0.25, p = .357). There were no statistically significant differences in polysomnography‐derived sleep architecture values between sham and stimulation conditions in either young or older adults. Based on these results, it appears that acoustic stimulation during sleep may only be an effective intervention for declarative memory consolidation in young adults. However, the small number of studies in this area, their small sample sizes, the short‐term nature of most investigations and the high between‐studies heterogeneity highlight a need for high‐powered and long‐term experiments to better elucidate, and subsequently maximise, any potential benefits of this novel approach.
- 30 November 2021
- Published by Wiley in Journal of Sleep Research
- Vol. 31 (3) , e13385
RetractedRETRACTED: The impact of acoustic stimulation during sleep on memory and sleep architecture: A meta‐analysis
Summary: The relationship between sleep and cognition has long been recognized, with slow‐wave sleep thought to play a critical role in long‐term memory consolidation. Recent research has presented the possibility that non‐invasive acoustic stimulation during sleep could enhance memory consolidation. Herein, we report a random‐effects model meta‐analysis examining the impact of this intervention on memory and sleep architecture in healthy adults. Sixteen studies were identified through a systematic search. We found a medium significant effect of acoustic stimulation on memory task performance (g = 0.68, p = .031) in young adults 35 years of age (g = −0.83, p = .223). In young adults, there was a large statistically significant effect for declarative memory tasks (g = 0.87, p = .014) but no effect for non‐declarative tasks (g = −0.25, p = .357). There were no statistically significant differences in polysomnography‐derived sleep architecture values between sham and stimulation conditions in either young or older adults. Based on these results, it appears that acoustic stimulation during sleep may only be an effective intervention for declarative memory consolidation in young adults. However, the small number of studies in this area, their small sample sizes, the short‐term nature of most investigations and the high between‐studies heterogeneity highlight a need for high‐powered and long‐term experiments to better elucidate, and subsequently maximise, any potential benefits of this novel approach.
- Top Cited PapersOpen Access
- 19 October 2021
- Published by Wolters Kluwer Health in Neurology
- Vol. 97 (16) , e1620-e1631
Subjective Sleep Quality and Sleep Architecture in Patients With Migraine
Background and Objectives Sleep disturbance is often associated with migraine. However, there is a paucity of research investigating objective and subjective measures of sleep in patients with migraine. This meta-analysis aims to determine whether there are differences in subjective sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI) and objective sleep architecture measured using polysomnography (PSG) between adult and pediatric patients and healthy controls. Methods This review was preregistered on PROSPERO (CRD42020209325). A systematic search of 5 databases (Embase, MEDLINE, Global Health, APA PsycINFO, and APA PsycArticles, last searched on December 17, 2020) was conducted to find case–control studies that measured PSG or PSQI in patients with migraine. Pregnant participants and those with other headache disorders were excluded. Effect sizes (Hedges g) were entered into a random effects model meta-analysis. Study quality was evaluated with the Newcastle Ottawa Scale and publication bias with the Egger regression test. Results Thirty-two studies were eligible, of which 21 measured PSQI or Migraine Disability Assessment Test in adults, 6 measured PSG in adults, and 5 measured PSG in children. The overall mean study quality score was 5/9; this did not moderate any of the results and there was no risk of publication bias. Overall, adults with migraine had higher PSQI scores than healthy controls (g = 0.75, p < 0.001, 95% confidence interval [CI] 0.54–0.96). This effect was larger in those with a chronic rather than episodic condition (g = 1.03, p < 0.001, 95% CI 0.37–1.01; g = 0.63, p < 0.001, 95% CI 0.38–0.88, respectively). For polysomnographic studies, adults and children with migraine displayed a lower percentage of rapid eye movement sleep (g = −0.22, p = 0.017, 95% CI −0.41 to −0.04; g = −0.71, p = 0.025, 95% CI −1.34 to −0.10, respectively) than controls. Pediatric patients displayed less total sleep time (g = −1.37, p = 0.039, 95% CI −2.66 to −0.10), more wake (g = 0.52, p < 0.001, 95% CI 0.08–0.79), and shorter sleep onset latency (g = −0.37, p < 0.001, 95% CI −0.54 to −0.21) than controls. Discussion People with migraine have significantly poorer subjective sleep quality and altered sleep architecture compared to healthy individuals. Further longitudinal empirical studies are required to enhance our understanding of this relationship.
- 19 October 2021
- Published by Wolters Kluwer Health in Neurology
- Vol. 97 (16) , e1620-e1631
Top Cited PapersOpen AccessSubjective Sleep Quality and Sleep Architecture in Patients With Migraine
Background and Objectives Sleep disturbance is often associated with migraine. However, there is a paucity of research investigating objective and subjective measures of sleep in patients with migraine. This meta-analysis aims to determine whether there are differences in subjective sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI) and objective sleep architecture measured using polysomnography (PSG) between adult and pediatric patients and healthy controls. Methods This review was preregistered on PROSPERO (CRD42020209325). A systematic search of 5 databases (Embase, MEDLINE, Global Health, APA PsycINFO, and APA PsycArticles, last searched on December 17, 2020) was conducted to find case–control studies that measured PSG or PSQI in patients with migraine. Pregnant participants and those with other headache disorders were excluded. Effect sizes (Hedges g) were entered into a random effects model meta-analysis. Study quality was evaluated with the Newcastle Ottawa Scale and publication bias with the Egger regression test. Results Thirty-two studies were eligible, of which 21 measured PSQI or Migraine Disability Assessment Test in adults, 6 measured PSG in adults, and 5 measured PSG in children. The overall mean study quality score was 5/9; this did not moderate any of the results and there was no risk of publication bias. Overall, adults with migraine had higher PSQI scores than healthy controls (g = 0.75, p < 0.001, 95% confidence interval [CI] 0.54–0.96). This effect was larger in those with a chronic rather than episodic condition (g = 1.03, p < 0.001, 95% CI 0.37–1.01; g = 0.63, p < 0.001, 95% CI 0.38–0.88, respectively). For polysomnographic studies, adults and children with migraine displayed a lower percentage of rapid eye movement sleep (g = −0.22, p = 0.017, 95% CI −0.41 to −0.04; g = −0.71, p = 0.025, 95% CI −1.34 to −0.10, respectively) than controls. Pediatric patients displayed less total sleep time (g = −1.37, p = 0.039, 95% CI −2.66 to −0.10), more wake (g = 0.52, p < 0.001, 95% CI 0.08–0.79), and shorter sleep onset latency (g = −0.37, p < 0.001, 95% CI −0.54 to −0.21) than controls. Discussion People with migraine have significantly poorer subjective sleep quality and altered sleep architecture compared to healthy individuals. Further longitudinal empirical studies are required to enhance our understanding of this relationship.
- Open Access
Subjective sleep quality and objective sleep physiology in migraineurs: a meta-analysis
Objectives: Sleep disturbance is often associated with migraine. However, there is a paucity of research investigating objective and subjective measures of sleep in migraineurs. This meta-analysis aims to determine whether there are differences in subjective sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI) and objective sleep physiology measured using polysomnography between adult and pediatric migraineurs, and healthy controls. Methods: A systematic search of five databases was conducted to find case-controlled studies which measured polysomnography and/or PSQI in migraineurs. Effect sizes (Hedges’ g ) were entered into a random effects model meta-analysis. Results: 32 separate studies were eligible. Overall, adult migraineurs had higher PSQI scores than healthy controls ( g = 0.75, p < .001). This effect was larger in chronic than episodic migraineurs ( g = 1.03, p < .001, g = 0.63, p < .001 respectively). For polysomnographic studies, adult and pediatric migraineurs displayed a lower percentage of REM sleep ( g = −0.22, p = 0.017, g = −0.71, p = 0.025 respectively) than healthy controls. Pediatric migraineurs also displayed less total sleep time ( g = −1.37, p = 0.039), more wake ( g = 0.52, p < .001) and shorter sleep onset latency ( g = −0.37, p < .001) than healthy controls. Conclusion: Migraineurs have significantly poorer subjective sleep quality, and altered sleep compared to healthy individuals – a finding which is particularly evident in children. This has implications for developing appropriate treatments. Further longitudinal empirical studies are required to enhance our understanding of this relationship.
Open AccessSubjective sleep quality and objective sleep physiology in migraineurs: a meta-analysis
Objectives: Sleep disturbance is often associated with migraine. However, there is a paucity of research investigating objective and subjective measures of sleep in migraineurs. This meta-analysis aims to determine whether there are differences in subjective sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI) and objective sleep physiology measured using polysomnography between adult and pediatric migraineurs, and healthy controls. Methods: A systematic search of five databases was conducted to find case-controlled studies which measured polysomnography and/or PSQI in migraineurs. Effect sizes (Hedges’ g ) were entered into a random effects model meta-analysis. Results: 32 separate studies were eligible. Overall, adult migraineurs had higher PSQI scores than healthy controls ( g = 0.75, p < .001). This effect was larger in chronic than episodic migraineurs ( g = 1.03, p < .001, g = 0.63, p < .001 respectively). For polysomnographic studies, adult and pediatric migraineurs displayed a lower percentage of REM sleep ( g = −0.22, p = 0.017, g = −0.71, p = 0.025 respectively) than healthy controls. Pediatric migraineurs also displayed less total sleep time ( g = −1.37, p = 0.039), more wake ( g = 0.52, p < .001) and shorter sleep onset latency ( g = −0.37, p < .001) than healthy controls. Conclusion: Migraineurs have significantly poorer subjective sleep quality, and altered sleep compared to healthy individuals – a finding which is particularly evident in children. This has implications for developing appropriate treatments. Further longitudinal empirical studies are required to enhance our understanding of this relationship.